Omadacycline: A Modernized Tetracycline

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Jason C Gallagher

Abstract

When tetracyclines were introduced in the 1940s, these antibiotics offered a broad spectrum of activity against multiple types of pathogens. However, their utility waned after the selection of tetracycline resistance in the pathogens against which they were effective. Omadacycline is a semisynthetic aminomethylcycline antibacterial derived from the tetracycline class of antibiotics that is unaffected by these resistance mechanisms. It has an appropriate spectrum of activity for community-acquired infections, including those caused by many resistant organisms. Omadacycline offers a well-tolerated treatment for acute bacterial skin and skin structure infections and community-acquired bacterial pneumonia. Omadacycline has minimal known drug-drug interactions, and should be administered in a fasting state, avoiding dairy and cation-containing products for at least 4 hours after dosing. It does not require dose adjustments for sex, age, or hepatic or renal impairment, and has a safety profile similar to that of other oral tetracyclines. Because omadacycline can be administered effectively orally, it can help reduce hospitalization costs associated with intravenous antibiotic administration. This special supplement to Clinical Infect...Continue Reading

References

Jul 14, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Gary E Stein, William A Craig
Mar 4, 2008·The Journal of Antimicrobial Chemotherapy·Carl AscheC Daniel Mullins
Jan 26, 2010·Primary Care Companion to the Journal of Clinical Psychiatry·Davin K Quinn, Theodore A Stern
Mar 30, 2010·Journal of Pain & Palliative Care Pharmacotherapy· U S Food And Drug Administration
Aug 10, 2010·American Journal of Respiratory and Critical Care Medicine·Grant W WatererRichard G Wunderink
Sep 16, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy C JenkinsWilliam J Burman
Dec 24, 2011·Annals of the New York Academy of Sciences·Mark L Nelson, Stuart B Levy
Sep 18, 2013·Antimicrobial Agents and Chemotherapy·Michael P DraperStuart B Levy
Oct 31, 2013·Journal of the American Association of Nurse Practitioners·Cherese SeversonMeg Fitzhugh
Dec 4, 2013·Antimicrobial Agents and Chemotherapy·A B MaconeS B Levy
Sep 13, 2014·Journal of Infection in Developing Countries·Sujith J ChandyCecilia Stalsby Lundborg
Jan 15, 2015·Current Microbiology·Jakub KwiecinskiTao Jin
Jul 23, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C EckmannS Haider
Sep 10, 2015·Antimicrobial Agents and Chemotherapy·Laura HoneymanStuart Levy
Dec 17, 2015·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·George H TalbotUNKNOWN Biomarkers Consortium of the Foundation for the National Institutes of Health CABP-ABSSSI and HABP-VABP Project Teams
Apr 30, 2016·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A RussoM Bassetti
Jun 2, 2016·Expert Review of Clinical Pharmacology·Jaime E VerasteguiDavid P Nicolau
Aug 9, 2016·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Jimmy FlarakosJames B Mangold
Aug 20, 2016·Journal of Clinical Pharmacology·Evan TzanisEvan Loh
Feb 15, 2017·Antimicrobial Agents and Chemotherapy·Alexander J LepakDavid R Andes
May 13, 2017·Clinical Therapeutics·Susan K PaulsonSue K Cammarata
Dec 19, 2017·Current Opinion in Infectious Diseases·Philippe MontraversSebastien Tanaka
Apr 7, 2018·Clinical Pharmacokinetics·Charlotte GranhallThomas W Anderson
Oct 10, 2018·Emergency Medicine Clinics of North America·Amelia Breyre, Bradley W Frazee
Feb 7, 2019·The New England Journal of Medicine·William O'RiordanEvan Loh
Feb 7, 2019·The New England Journal of Medicine·Roman StetsEvan Loh
Aug 2, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Steven OpalPaul C McGovern
Aug 2, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Julio A RamirezPaul C McGovern
Aug 2, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fredrick M AbrahamianPaul C McGovern
Aug 2, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James A KarlowskyGeorge G Zhanel
Aug 2, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Keith A Rodvold, Manjunath P Pai

❮ Previous
Next ❯

Citations

Jul 22, 2020·Antimicrobial Agents and Chemotherapy·Sara E BoydWilliam W Hope
Jan 24, 2020·Drugs·George G ZhanelJames A Karlowsky
Jun 27, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Rafik KaramanZeinab Breijyeh
Sep 20, 2020·International Journal of Molecular Sciences·Michal Meir, Daniel Barkan
Dec 9, 2020·Antimicrobial Agents and Chemotherapy·Barbara A Brown-Elliott, Richard J Wallace
Feb 26, 2021·Open Forum Infectious Diseases·Taylor MorrisetteMichael J Rybak
Apr 4, 2021·Microorganisms·Corneliu Ovidiu VrancianuMariana Carmen Chifiriuc
May 12, 2021·Antimicrobial Agents and Chemotherapy·Kavindra V Singh, Barbara E Murray

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Richard R Watkins, Stan Deresinski
Infection and Drug Resistance
Rodrigo M Burgos, Keith A Rodvold
© 2021 Meta ULC. All rights reserved